InnovAge Holding Corp. (INNV)
USD 3.75
(-8.09%)
USD 3.75
(-8.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -21.33 Million USD | 47.54% |
| 2023 | -40.67 Million USD | -410.97% |
| 2022 | -7.96 Million USD | 82.21% |
| 2021 | -44.74 Million USD | -270.26% |
| 2020 | 26.27 Million USD | 34.22% |
| 2019 | 19.57 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -21.33 Million USD | 47.54% |
| 2024 Q2 | -3.44 Million USD | 66.55% |
| 2024 Q4 | -1.7 Million USD | 71.12% |
| 2024 Q1 | -10.3 Million USD | 7.81% |
| 2024 Q3 | -5.88 Million USD | -70.79% |
| 2023 Q3 | -7.31 Million USD | 30.69% |
| 2023 FY | -40.67 Million USD | -410.97% |
| 2023 Q4 | -11.17 Million USD | -52.9% |
| 2023 Q2 | -10.54 Million USD | 23.01% |
| 2023 Q1 | -13.69 Million USD | -1.23% |
| 2022 Q3 | -3.15 Million USD | -338.7% |
| 2022 Q4 | -13.53 Million USD | -328.5% |
| 2022 Q1 | 7.68 Million USD | 18.72% |
| 2022 Q2 | 1.32 Million USD | -82.79% |
| 2022 FY | -7.96 Million USD | 82.21% |
| 2021 Q4 | 6.47 Million USD | 161.6% |
| 2021 FY | -44.74 Million USD | -270.26% |
| 2021 Q2 | 9.7 Million USD | 119.55% |
| 2021 Q3 | -10.51 Million USD | -208.29% |
| 2021 Q1 | -49.65 Million USD | -510.47% |
| 2020 Q3 | 8.13 Million USD | 0.0% |
| 2020 Q4 | 12.09 Million USD | 48.65% |
| 2020 FY | 26.27 Million USD | 34.22% |
| 2019 FY | 19.57 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 1.518% |
| Addus HomeCare Corporation | 62.51 Million USD | 134.132% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -376.401% |
| Amedisys, Inc. | -9.74 Million USD | -118.919% |
| American Oncology Network, Inc. | -5.54 Million USD | -285.023% |
| Astrana Health, Inc. | 60.71 Million USD | 135.143% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 84.138% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 743.486% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -124.099% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 129.379% |
| COMPASS Pathways plc | -118.46 Million USD | 81.988% |
| DocGo Inc. | 6.85 Million USD | 411.12% |
| The Ensign Group, Inc. | 209.39 Million USD | 110.19% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 155.588% |
| Assure Holdings Corp. | -26.07 Million USD | 18.176% |
| The Joint Corp. | -9.75 Million USD | -118.802% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 88.544% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | -36.758% |
| ModivCare Inc. | -204.46 Million USD | 89.564% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 16489.514% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | -61.474% |
| Option Care Health, Inc. | 267.09 Million USD | 107.989% |
| P3 Health Partners Inc. | -57.77 Million USD | 63.066% |
| P3 Health Partners Inc. | -57.77 Million USD | 63.066% |
| The Pennant Group, Inc. | 13.37 Million USD | 259.489% |
| Surgery Partners, Inc. | -11.9 Million USD | -79.311% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -626.192% |
| Talkspace, Inc. | -19.18 Million USD | -11.24% |
| Talkspace, Inc. | -19.18 Million USD | -11.24% |
| The Oncology Institute, Inc. | -83.06 Million USD | 74.313% |
| The Oncology Institute, Inc. | -83.06 Million USD | 74.313% |